Track topics on Twitter Track topics that are important to you
Guardion Health Sciences announced it has completed a Series B funding round with $3.1 million raised, according to a company press release.The money is to be used in accelerating expansion of the company’s operations, implementing its sales and marketing strategy, and completing development of products in its pipeline, the release said.
Original Article: Guardion Health Sciences completes Series B fundingNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...